fluorouracil and nvp-cgm097

fluorouracil has been researched along with nvp-cgm097 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aristizabal Prada, ET; Auernhammer, CJ; Hahner, S; Halilovic, E; Heinzle, V; Herterich, S; Jeay, S; Maurer, J; Nölting, S; Reuther, C; Spöttl, G; Wuerthner, JU	1

Other Studies

1 other study(ies) available for fluorouracil and nvp-cgm097

Article	Year
The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. Neuroendocrinology, 2018, Volume: 106, Issue:1 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; E2F1 Transcription Factor; Fluorouracil; Humans; Isoquinolines; Neuroendocrine Tumors; Piperazines; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Signal Transduction; Tumor Suppressor Protein p53	2018

Article

Year

The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1.

Neuroendocrinology, 2018, Volume: 106, Issue:1

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Therapy, Combination; E2F1 Transcription Factor; Fluorouracil; Humans; Isoquinolines; Neuroendocrine Tumors; Piperazines; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Signal Transduction; Tumor Suppressor Protein p53

2018